{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:09:17Z","timestamp":1724144957422},"reference-count":17,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3960\/jslrt.23020","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T22:15:20Z","timestamp":1690496120000},"page":"181-186","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse large B-cell lymphoma with composite germinal center and                    non-germinal center types: A report of two cases"],"prefix":"10.3960","volume":"63","author":[{"given":"Ayumi","family":"Sugitani","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, National                            Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer                            Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer                            Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Ichihara","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, National                            Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer                            Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko Miyagi","family":"Maeshima","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, National                            Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Ott G, Siebert R, Coupland SE, et al. Diffuse                    large B-cell lymphoma, NOS. In : World Health Organ Class of Tumours Editorial                    Board (eds) : Haematolymphoid Tumours [Internet; beta version ahead of print].                    Lyon, International Agency for Research on Cancer. 2022 [cited 2023\/05\/17]. (WHO                    classification of tumours series, 5<sup>th<\/sup> ed.; vol. 11). Available from:                    https:                    \/\/tumourclassification.iarc.who.int\/chaptercontent\/63\/157."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Alizadeh                            AA,                                Eisen                            MB,                                Davis                            RE                    <i>et al.<\/i> Distinct types of diffuse large B-cell lymphoma                    identified by gene expression profiling. Nature. 2000; 403:                    503-511.","DOI":"10.1038\/35000501"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Rosenwald                            A,                                Wright                            G,                                Chan                            WC                    <i>et al.<\/i> Lymphoma\/Leukemia Molecular Profiling Project. The use                    of molecular profiling to predict survival after chemotherapy for diffuse                    large-B-cell lymphoma. N Engl J Med. 2002; 346: 1937-1947.","DOI":"10.1056\/NEJMoa012914"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Lenz                            G,                                Wright                            G,                                Dave                            SS                    <i>et al.<\/i> Lymphoma\/Leukemia Molecular Profiling Project. Stromal                    gene signatures in large-B-cell lymphomas. N Engl J Med. 2008; 359:                    2313-2323.","DOI":"10.1056\/NEJMoa0802885"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Hans                            CP,                                Weisenburger                            DD,                                Greiner                            TC                    <i>et al.<\/i> Confirmation of the molecular classification of diffuse                    large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood.                    2004; 103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Siddiqi                            IN,                                Shibata                            D. Diffuse large                    B-cell lymphoma of germinal center and nongerminal center phenotypes presenting                    concurrently at the same anatomic site: intratumoral heterogeneity or composite                    lymphoma? Appl Immunohistochem Mol Morphol. 2015; 23: 78-80.","DOI":"10.1097\/PAI.0000000000000027"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wilson                            WH,                                Young                            RM,                                Schmitz                            R                    <i>et al.<\/i> Targeting B cell receptor signaling with ibrutinib in                    diffuse large B cell lymphoma. Nat Med. 2015; 21: 922-926.","DOI":"10.1038\/nm.3884"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Vitolo                            U,                                Chiappella                            A,                                Franceschetti                            S                    <i>et al.<\/i> Lenalidomide plus R-CHOP21 in elderly patients with                    untreated diffuse large B-cell lymphoma: results of the REAL07 open-label,                    multicentre, phase 2 trial. Lancet Oncol. 2014; 15: 730-737.","DOI":"10.1016\/S1470-2045(14)70191-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Nowakowski                            GS,                                LaPlant                            B,                                Macon                            WR                    <i>et al.<\/i> Lenalidomide combined with R-CHOP overcomes negative                    prognostic impact of non-germinal center B-cell phenotype in newly diagnosed                    diffuse large B-cell lymphoma: a phase II study. J Clin Oncol. 2015; 33:                    251-257.","DOI":"10.1200\/JCO.2014.55.5714"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Tilly                            H,                                Morschhauser                            F,                                Sehn                            LH                    <i>et al.<\/i> Polatuzumab vedotin in previously untreated diffuse                    large B-cell lymphoma. N Engl J Med. 2022; 386: 351-363.","DOI":"10.1056\/NEJMoa2115304"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Davies                            AJ,                                Rosenwald                            A,                                Wright                            G                    <i>et al.<\/i> Transformation of follicular lymphoma to diffuse large                    B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol. 2007;                    136: 286-293.","DOI":"10.1111\/j.1365-2141.2006.06439.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Maeshima                            AM,                                Omatsu                            M,                                Nomoto                            J                    <i>et al.<\/i> Diffuse large B-cell lymphoma after transformation from                    low-grade follicular lymphoma: morphological, immunohistochemical, and FISH                    analyses. Cancer Sci. 2008; 99: 1760-1768.","DOI":"10.1111\/j.1349-7006.2008.00873.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kridel                            R,                                Chan                            FC,                                Mottok                            A                    <i>et al.<\/i> Histological transformation and progression in                    follicular lymphoma: a clonal evolution study. PLoS Med. 2016; 13:                        e1002197.","DOI":"10.1371\/journal.pmed.1002197"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Maeshima                            AM,                                Taniguchi                            H,                                Toyoda                            K                    <i>et al.<\/i> Clinicopathological features of histological                    transformation from extranodal marginal zone B-cell lymphoma of                    mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis                    of 467 patients. Br J Haematol. 2016; 174: 923-931.","DOI":"10.1111\/bjh.14153"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Goyal                            G,                                Nguyen                            AH,                                Kendric                            K,                                Caponetti                            GC. Composite                    lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma                    components: A case report and review of the literature. Pathol Res Pract. 2016;                    212: 1179-1190.","DOI":"10.1016\/j.prp.2016.11.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kanzler                            H,                                K\u00fcppers                            R,                                Hansmann                            ML,                                Rajewsky                            K. Hodgkin and                    Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant                    tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;                    184: 1495-1505.","DOI":"10.1084\/jem.184.4.1495"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Marafioti                            T,                                Hummel                            M,                                Foss                            HD                    <i>et al.<\/i> Hodgkin and Reed-Sternberg cells represent an expansion                    of a single clone originating from a germinal center B-cell with functional                    immunoglobulin gene rearrangements but defective immunoglobulin transcription.                    Blood. 2000; 95: 1443-1450.","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/3\/63_23020\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T05:06:35Z","timestamp":1696050395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/3\/63_23020\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23020","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"23020"}}